StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

PMV Pharmaceuticals's cash was $79.43M at Jun 30, 2026. For fiscal 2025 it was $112.94M, down 38.4% from the year before. The highest annual figure on record is $361.42M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$112.94M-38.4%
FY2024Dec 31, 2024$183.30M-19.8%
FY2023Dec 31, 2023$228.56M-6.2%
FY2022Dec 31, 2022$243.55M-22.5%
FY2021Dec 31, 2021$314.07M-13.1%
FY2020Dec 31, 2020$361.42M+256.1%
FY2019Dec 31, 2019$101.49M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$79.43M-46.4%
Q1 FY2026Mar 31, 2026$93.55M-43.6%
Q4 FY2025Dec 31, 2025$112.94M-38.4%
Q3 FY2025Sep 30, 2025$129.25M-34.7%
Q2 FY2025Jun 30, 2025$148.31M-30.3%
Q1 FY2025Mar 31, 2025$165.82M-22.2%
Q4 FY2024Dec 31, 2024$183.30M-19.8%
Q3 FY2024Sep 30, 2024$197.94M-16.9%
Q2 FY2024Jun 30, 2024$212.92M-2.7%
Q1 FY2024Mar 31, 2024$213.06M-7.1%
Q4 FY2023Dec 31, 2023$228.56M-6.2%
Q3 FY2023Sep 30, 2023$238.10M-8.0%
Q2 FY2023Jun 30, 2023$218.84M-21.1%
Q1 FY2023Mar 31, 2023$229.43M-22.2%
Q4 FY2022Dec 31, 2022$243.55M-22.5%
Q3 FY2022Sep 30, 2022$258.86M-15.9%
Q2 FY2022Jun 30, 2022$277.43M-12.9%
Q1 FY2022Mar 31, 2022$294.77M-11.1%
Q4 FY2021Dec 31, 2021$314.07M-13.1%
Q3 FY2021Sep 30, 2021$307.65M-17.6%
Q2 FY2021Jun 30, 2021$318.35M+213.7%
Q1 FY2021Mar 31, 2021$331.49M–
Q4 FY2020Dec 31, 2020$361.42M–
Q3 FY2020Sep 30, 2020$373.15M–
Q4 FY2019Dec 31, 2019$101.49M–

More PMV Pharmaceuticals figures

See a number that looks wrong?